129 related articles for article (PubMed ID: 37873945)
1. Co-occurring conditions in Down syndrome: Findings from a clinical database.
Baumer NT; Hojlo MA; Pawlowski KG; Milliken AL; Lombardo AM; Sargado S; Soccorso C; Davidson EJ; Barbaresi WJ
Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32072. PubMed ID: 37873945
[TBL] [Abstract][Full Text] [Related]
2. Co-occurring conditions in children with Down syndrome and autism: a retrospective study.
Spinazzi NA; Santoro JD; Pawlowski K; Anzueto G; Howe YJ; Patel LR; Baumer NT
J Neurodev Disord; 2023 Mar; 15(1):9. PubMed ID: 36864370
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic.
Weas S; Pawlowski K; Miller M; DePillis R; Baumer N
J Child Adolesc Psychopharmacol; 2024 Jul; ():. PubMed ID: 38968386
[No Abstract] [Full Text] [Related]
4. Development and implementation of a longitudinal clinical database for down syndrome in a large pediatric specialty clinic: Methodology and feasibility.
Baumer NT; Hojlo MA; Lombardo AM; Milliken AL; Pawlowski KG; Sargado S; Soccorso C; Davidson EJ; Barbaresi WJ
J Intellect Disabil; 2024 Mar; 28(1):196-215. PubMed ID: 36245216
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Developmental Behavioral Pediatrics in a Population of Children with Down Syndrome.
Shaw D; Bar S; Champion JD
J Pediatr Nurs; 2021; 57():38-42. PubMed ID: 33212345
[TBL] [Abstract][Full Text] [Related]
6. Identifying Associations Among Co-Occurring Medical Conditions in Children With Autism Spectrum Disorders.
Neumeyer AM; Anixt J; Chan J; Perrin JM; Murray D; Coury DL; Bennett A; Farmer J; Parker RA
Acad Pediatr; 2019 Apr; 19(3):300-306. PubMed ID: 30053632
[TBL] [Abstract][Full Text] [Related]
7. Neurodevelopmental disorders: prevalence and comorbidity in children referred to mental health services.
Hansen BH; Oerbeck B; Skirbekk B; Petrovski BÉ; Kristensen H
Nord J Psychiatry; 2018 May; 72(4):285-291. PubMed ID: 29488416
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of co-occurring autism spectrum disorder and attention deficit/hyperactivity disorder among children in the United States.
Casseus M
Autism; 2022 Aug; 26(6):1591-1597. PubMed ID: 35362330
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.
Chawner SJRA; Owen MJ; Holmans P; Raymond FL; Skuse D; Hall J; van den Bree MBM
Lancet Psychiatry; 2019 Jun; 6(6):493-505. PubMed ID: 31056457
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of neurodevelopmental disorders in a clinically referred sample of children with CHD.
Loblein HJ; Vukmirovich PW; Donofrio MT; Sanz JH
Cardiol Young; 2023 Apr; 33(4):619-626. PubMed ID: 36094009
[TBL] [Abstract][Full Text] [Related]
11. Executive functions among youth with Down Syndrome and co-existing neurobehavioural disorders.
Pritchard AE; Kalback S; McCurdy M; Capone GT
J Intellect Disabil Res; 2015 Dec; 59(12):1130-41. PubMed ID: 26369785
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life and Family Impact in Down Syndrome, Autism Spectrum Disorder, and Co-occurring Down Syndrome and Autism Spectrum Disorder.
Soccorso C; Milliken A; Hojlo M; Pawlowski K; Weas S; Sideridis G; Baumer N
J Dev Behav Pediatr; 2023 Apr; 44(3):e185-e195. PubMed ID: 36978233
[TBL] [Abstract][Full Text] [Related]
13. Co-occurring Down Syndrome and Autism Spectrum Disorder: Cognitive, Adaptive, and Behavioral Characteristics.
Bradbury KR; Anderberg EI; Huang-Storms L; Vasile I; Greene RK; Duvall SW
J Autism Dev Disord; 2022 Mar; 52(3):1235-1246. PubMed ID: 33905067
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of autism and attention-deficit-hyperactivity disorder in Down syndrome: a population-based study.
Oxelgren UW; Myrelid Å; Annerén G; Ekstam B; Göransson C; Holmbom A; Isaksson A; Åberg M; Gustafsson J; Fernell E
Dev Med Child Neurol; 2017 Mar; 59(3):276-283. PubMed ID: 27503703
[TBL] [Abstract][Full Text] [Related]
15. Maternal prenatal selenium levels and child risk of neurodevelopmental disorders: A prospective birth cohort study.
Lee ASE; Ji Y; Raghavan R; Wang G; Hong X; Pearson C; Mirolli G; Bind E; Steffens A; Mukherjee J; Haltmeier D; Fan ZT; Wang X
Autism Res; 2021 Dec; 14(12):2533-2543. PubMed ID: 34558795
[TBL] [Abstract][Full Text] [Related]
16. Genetic and environmental contributions to co-occurring physical health conditions in autism spectrum condition and attention-deficit/hyperactivity disorder.
Pan PY; Taylor MJ; Larsson H; Almqvist C; Lichtenstein P; Lundström S; Bölte S
Mol Autism; 2023 Apr; 14(1):17. PubMed ID: 37085910
[TBL] [Abstract][Full Text] [Related]
17. Associations among co-occurring medical conditions and cognition, language, and behavior in Down syndrome.
Schworer EK; Ahmed A; Hogenkamp L; Moore S; Esbensen AJ
Res Dev Disabil; 2022 Jul; 126():104236. PubMed ID: 35468571
[TBL] [Abstract][Full Text] [Related]
18. Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations.
Baumer NT; Capone G
Am J Med Genet C Semin Med Genet; 2023 Dec; 193(4):e32069. PubMed ID: 37870763
[TBL] [Abstract][Full Text] [Related]
19. Co-morbidity in Attention-Deficit Hyperactivity Disorder: A Clinical Study from India.
Jacob P; Srinath S; Girimaji S; Seshadri S; Sagar JV
East Asian Arch Psychiatry; 2016 Dec; 26(4):148-53. PubMed ID: 28053283
[TBL] [Abstract][Full Text] [Related]
20. How does brain structure and function on MRI differ in children with autism spectrum disorder, developmental coordination disorder, and/or attention deficit hyperactivity disorder?
Kangarani-Farahani M; Izadi-Najafabadi S; Zwicker JG
Int J Dev Neurosci; 2022 Dec; 82(8):681-715. PubMed ID: 36084947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
